Utang jangka cendhak marang ekuitas Aadi Bioscience Inc (WHWK)

Logo grafis Aadi Bioscience Inc (WHWK)

The price history of Aadi Bioscience Inc (WHWK) shares on the GURU.Markets platform reflects the dynamics of a company creating a precision environment for the therapy of rare neoplasms using the mTor platform, where the indicator stands at 0.00. The business relies on monopolizing the ultra-rare pathology niche, which eliminates dumping by manufacturers of analogous products. Consequently, Aadi Bioscience Inc is developing a unique mechanism to combat mTOR-dependent cells, offering an unrivaled lifeline for individuals with orphan diagnoses.

WHWK - Rasio utang jangka cendhak marang ekuitas Aadi Bioscience Inc ing rentang 20.03.2025 - 29.10.2026
Produk mawa merek aadibio.com

This ratio measures the share of liabilities maturing within one year relative to equity, determining the level of short-term debt load and liquidity risk. Analyzing the ratio of loans under one year to equity for Aadi Bioscience Inc (WHWK) is critical, as a high dependence on a single oncology drug makes the company vulnerable to cash flow gaps until the product achieves commercial success.

Pesaing Aadi Bioscience Inc

Utang jangka cendhak marang modal ONC|Utang jangka cendhak marang modal Halozyme Corp (HALO)|Utang jangka cendhak marang ekuitas Revolution Medicines RVMD|AAPG: Rasio utang jangka cendhak marang modal|CG Oncology - Utang jangka cendhak marang modal|UroGen Pharma Ltd (URGN) - Rasio utang jangka cendhak marang ekuitas|BCAX: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Personalis Genomics (PSNL)|Utang jangka cendhak marang ekuitas Erasca, Inc.|DCTH: Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas YMAB (Y-mAbs Therapeutics, Inc.)|AURA (Aura Biosciences Inc) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal CADL (Candel Therapeutics, Inc.)|ARAY - Rasio utang jangka cendhak marang ekuitas|SLS: Rasio utang jangka cendhak marang ekuitas|ACTU - Utang jangka cendhak marang modal|Citius Oncology (CTOR) - Utang jangka cendhak marang ekuitas|TuHURA Biosciences - Rasio tanggungan utang jangka cendhak marang modal|TARA (Protara) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Fate Pharma FATE|Utang jangka cendhak marang modal TCRX|Utang jangka cendhak marang modal championsoncology.com (CSBR)|Utang jangka cendhak marang modal XBIT (XBiotech)|Utang jangka cendhak marang modal CEL-SCI Corp. CVM|OS Therapies Inc - Utang jangka cendhak marang modal|RADX (Radiopharm Theranostics Ltd) - Rasio utang jangka cendhak marang modal|ARTV: Utang jangka cendhak marang modal|ANL - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas VERU|TPST: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal XLO|Utang jangka cendhak marang ekuitas RENB (renovarobio.com)|Utang jangka cendhak marang modal MURA (Mural Oncology)|Koefisien utang jangka cendhak marang modal Kairos Pharma Limited (KAPA)|OKUR - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal CytoMed Therapeutics|curis.com (CRIS) - Utang jangka cendhak marang ekuitas|APLM - Koefisien utang jangka cendhak marang modal|THAR (Tharimmune, Inc.) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Advanced Biomed Corp (ADVB)|Utang jangka cendhak marang modal GNPX|Koefisien utang jangka cendhak marang modal calidibio.com|Utang jangka cendhak marang modal SBFM (Sunshine Biopharma)|Xenetic Biosciences Inc. (XBIO) - Kewajiban jangka cendhak marang modal|SLRX - Utang jangka cendhak marang ekuitas|PPBT (purple-biotech.com) - Rasio utang jangka cendhak marang modal|AONC: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas BeiGene Ltd.|CKPT (Checkpoint Therapeutics, Inc) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Elevation Oncology Inc. ELEV|Rasio utang jangka cendhak marang ekuitas ICAD (iCAD, Inc.)|IKNA (ikenaoncology.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal NTBL (Notable Labs)|Koefisien utang jangka cendhak marang modal Viracta Therapeutics Inc. (VIRX)|MOR - Utang jangka cendhak marang ekuitas|NAYA (NAYA Biosciences Corp) - Rasio utang jangka cendhak marang modal|AAPGV: Utang jangka cendhak marang modal